Blood triglyceride level (null)

Blood triglyceride level refers to the concentration of triglycerides—a type of fat—in the bloodstream. Triglycerides are formed from three fatty acids attached to a glycerol backbone. They are either absorbed from dietary fats or synthesized in the liver from excess calories. The body stores them in adipose tissue for later energy use. When needed for energy between meals or during fasting, hormones signal their release into circulation. Elevated blood triglyceride levels are associated with an increased risk for cardiovascular diseases such as coronary artery disease and stroke. Extremely high levels can cause acute pancreatitis. High blood concentrations often result from lifestyle factors like excessive calorie intake—especially sugars and fats—obesity, lack of exercise, alcohol use disorder, poorly controlled diabetes mellitus, certain medications, genetic disorders affecting lipid metabolism, thyroid dysfunctions or kidney/liver diseases. Triglycerides are measured routinely as part of a lipid panel during health checkups to assess cardiovascular risk. Normal fasting values are generally considered less than 150 mg/dL (<1.7 mmol/L). Borderline-high is 150‒199 mg/dL; high is 200‒499 mg/dL; very high is ≥500 mg/dL. Management focuses on lifestyle changes—diet modification to reduce simple carbohydrates and saturated fats; weight loss; regular physical activity—and sometimes pharmacologic therapy if lifestyle alone does not achieve target levels or if there is significant cardiovascular risk or pancreatitis threat[1][2][4]. Note: "Blood Triglyceride Levels" describes a clinical measurement, not a molecular target such as an enzyme/receptor/transporter/protein typically modulated directly by drugs. Therefore it should not be classified as a therapeutic target itself but rather as a biomarker used for diagnosis/risk assessment/monitoring response to therapy[1][2].

Other names

TriglyceridesSerum triglyceridePlasma triglycerideTG (in the context of laboratory tests)Blood fat (colloquial)

– Activation of peroxisome proliferator–activated receptors by fibrates to increase lipid metabolism – Inhibition of hepatic VLDL synthesis by statins and niacin – Reduction of hepatic triglyceride synthesis and increased clearance via omega‑3 fatty acids[1][2][4]